About me
Josh is the CEO and co-founder of Artos, which provides the AI-native document creation and management suite for drug development document creation and management. Prior to Artos, Josh worked in regulatory, clinical, and commercial strategy roles at Ignyta and Erasca where he focused on executing trials and securing FIH and marketing approvals with the US FDA, EMA, and PMDA. Josh also completed research at the University of Chicago, where his work focused on developing low-latency, unsupervised models for digital biomarker detection and natural language processing techniques for site selection and patient recruitment.
